130 related articles for article (PubMed ID: 26483003)
1. One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).
Ohki T; Angle JF; Yokoi H; Jaff MR; Popma J; Piegari G; Kanaoka Y;
J Vasc Surg; 2016 Feb; 63(2):370-6.e1. PubMed ID: 26483003
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Multicenter Comparison of S.M.A.R.T. CONTROL and MISAGO Stents in Treatment of Femoropopliteal Lesions.
Suzuki K; Takahara M; Shintani Y; Tanaka A; Soga Y; Yamaoka T; Tosaka A; Sasaki S; Kawasaki D; Tsuchiya T; Kozuki A; Iida O
J Vasc Interv Radiol; 2016 Nov; 27(11):1642-1649. PubMed ID: 27567999
[TBL] [Abstract][Full Text] [Related]
3. Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY Trial.
Angle JF; Gasparetto A; Yokoi H; Jaff MR; Popma JJ; Piegari GN; Iyengar SS; Ohki T
J Vasc Interv Radiol; 2020 Jun; 31(6):978-985. PubMed ID: 32414572
[TBL] [Abstract][Full Text] [Related]
4. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.
Lin Y; Tang X; Fu W; Kovach R; George JC; Guo D
J Endovasc Ther; 2015 Jun; 22(3):319-26. PubMed ID: 25862365
[TBL] [Abstract][Full Text] [Related]
5. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
[TBL] [Abstract][Full Text] [Related]
6. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients.
Schulte KL; Kralj I; Gissler HM; Bagnaschino LA; Buschmann I; Pernès JM; Haage P; Goverde P; Beregi JP; Válka M; Boudny J; Geibel T; Velkoborsky M; Zähringer M; Paetzel C; Fanelli F; Müller-Hülsbeck S; Zeller T; Langhoff R
J Endovasc Ther; 2012 Dec; 19(6):774-84. PubMed ID: 23210876
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
[TBL] [Abstract][Full Text] [Related]
8. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
9. Twelve-month results of the EverFlex stent in the superficial femoral artery.
Diehl SJ; Gerblich F; Jochum S; Huck K; Keese M; Schoenberg SO; Sadick M
J Vasc Interv Radiol; 2012 Oct; 23(10):1317-22. PubMed ID: 22840683
[TBL] [Abstract][Full Text] [Related]
10. First clinical experience with the Innova versus the Protege EverFlex self-expanding bare metal stents in superficial femoral artery occlusions.
Gabrielli R; Rosati MS; Chiappa R; Millarelli M; Marcuccio L; Siani A; Caselli G
Thorac Cardiovasc Surg; 2015 Mar; 63(2):158-63. PubMed ID: 25602844
[TBL] [Abstract][Full Text] [Related]
11. Bioabsorbable stent implantation vs. common femoral artery endarterectomy: early results of a randomized trial.
Linni K; Ugurluoglu A; Hitzl W; Aspalter M; Hölzenbein T
J Endovasc Ther; 2014 Aug; 21(4):493-502. PubMed ID: 25101576
[TBL] [Abstract][Full Text] [Related]
12. Novel Nitinol Stent for Lesions up to 24 cm in the Superficial Femoral and Proximal Popliteal Arteries: 24-Month Results From the TIGRIS Randomized Trial.
Laird JR; Zeller T; Loewe C; Chamberlin J; Begg R; Schneider PA; Nanjundappa A; Bunch F; Schultz S; Harlin S; Lansky A; Jaff MR
J Endovasc Ther; 2018 Feb; 25(1):68-78. PubMed ID: 29285955
[TBL] [Abstract][Full Text] [Related]
13. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
[TBL] [Abstract][Full Text] [Related]
14. Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.
Malas MB; Enwerem N; Qazi U; Brown B; Schneider EB; Reifsnyder T; Freischlag JA; Perler BA
J Vasc Surg; 2014 Jan; 59(1):129-35. PubMed ID: 23891488
[TBL] [Abstract][Full Text] [Related]
15. Mid-term outcome after endovascular therapy in the superficial femoral and popliteal artery using long stents.
Schoenefeld E; Donas KP; Schönefeld T; Osada N; Austermann M; Torsello G
Vasa; 2012 Jan; 41(1):49-56. PubMed ID: 22247060
[TBL] [Abstract][Full Text] [Related]
16. Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan.
Mori S; Hirano K; Yamauchi Y; Hayashi E; Doijiri T; Takamura T; Maeda A; Okuda J; Mizuno K; Onishi Y; Iwaki T; Tsukahara K; Shinozaki N; Araki H; Kongoji K; Sugano T; Miyamoto A; Michishita I
Heart Vessels; 2017 Sep; 32(9):1093-1098. PubMed ID: 28451834
[TBL] [Abstract][Full Text] [Related]
17. Deployment of self-expandable stents for complex proximal superficial femoral artery lesions involving the femoral bifurcation with or without jailed deep femoral artery.
Yamawaki M; Hirano K; Nakano M; Sakamoto Y; Takimura H; Araki M; Ishimori H; Ito Y; Tsukahara R; Muramatsu T
Catheter Cardiovasc Interv; 2013 May; 81(6):1031-41. PubMed ID: 22639451
[TBL] [Abstract][Full Text] [Related]
18. The effect of demographic factors and lesion severity on iliac stent patency.
Roach AN; Larion S; Ahanchi SS; Ammar CP; Brandt CT; Dexter DJ; Panneton JM
J Vasc Surg; 2015 Sep; 62(3):645-53. PubMed ID: 26094046
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions.
Piazza M; Squizzato F; Spolverato G; Milan L; Bonvini S; Menegolo M; Grego F; Antonello M
J Vasc Surg; 2015 Nov; 62(5):1210-8.e1. PubMed ID: 26254822
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3-year results from the STROLL study.
Bunte MC; Cohen DJ; Jaff MR; Gray WA; Magnuson EA; Li H; Feiring A; Cioppi M; Hibbard R; Gray B; Khatib Y; Jessup D; Patarca R; Du J; Stoll HP; Massaro J; Safley DM;
Catheter Cardiovasc Interv; 2018 Jul; 92(1):106-114. PubMed ID: 29521013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
